ArticleInternational journal of radiation oncology, biology, physics2014

Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo.

Lorenzo Agoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.